VGLS Notes Key Patents, License and Other Major Achievements in the First Half of 2015

SANTA BARBARA, Calif., June 16, 2015 /PRNewswire/ — Dear Shareholders, Here at VG Life Sciences (OTC-QB: VGLS), our mission is to save and improve lives through the development of transformative treatments for cancer, infectious diseases, and the chronic inflammation intrinsic to autoimmune diseases. We have made significant progress in a number of areas in the first…